Press "Enter" to skip to content

New patent for Exeltis Usa drug SLYND

0
Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug SLYND

Annual Drug Patent Expirations for SLYND
Annual Drug Patent Expirations for SLYND

Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug.

SLYND drug price trends.

This drug has fifty patent family members in twenty-seven countries.

The generic ingredient in SLYND is drospirenone. Additional details are available on the drospirenone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug SLYND
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions